AI & Healthcare News — 2026-10-09 (Fri) Morning News

Overview

- Mental health: The focus was on the use of generative AI for consultation, with concerns about guidelines for providers (initiatives by international organizations, government guidelines in Japan and South Korea), and conversational AI for teenagers. - Physical health: Focus on accuracy evaluation and commercialization of AI for individuals, such as identification accuracy of blood pressure monitors, wearable linkage, and analysis of meal photos. - How it works: In the US, there is a flurry of state-by-state AI regulations, FDA 510(k) approval, and a public offering of about 80 million pounds for dementia in the UK.

Mental health

- Partnership on AI launches new area of work on AI and psychological well-being (Business Wire). The details of the content are unclear from the headline. - TechCrunch reports: ChatGPT for Teens continues to talk to teens even in the midst of emotional crisis, headline says. The scale and method of evaluation are unknown. - King's College London has been ranked as one of the world's leading institutions in AI and mental health research (this is an evaluation of the research institution, not the effectiveness of interventions). - Teladoc announces new AI capabilities (Modern Healthcare). The content of the function is unknown. - STAT headline mentions AI psychosis. Contents unknown. - The IMDb article (comedian's discussion of AI anxiety) is not health research and will not be covered.

Exercise/physical activity

- Budy: Announcing AI Fitness Coach. A product that assists in planning training plans (ACCESS Newswire). Verification of effectiveness is not mentioned in the heading. - Sineco: Ships a wearable-linked app that adaptively generates music from biometric information (Dealroom). Verification of effectiveness is unknown. - Cal AI founder Zach Yadegari raises $10 million for new AI startup Persona (TechCrunch and others). The details of the business are unclear from the headline. - MyDefence's drone detector has been excluded as it has nothing to do with health.

sleep

- Starkey: Added sleep tracking and enhanced AI to hearing aid Omega AI+ (product feature announcement; accuracy verification unknown). - Natura: $99 smart ring with AI agent (The Tech Buzz) Measurement items and verification are unknown. - WELT (Korea): Plans to prepare AI agents for each prescription drug, the first being SleepQ (Korea Biomedical Review interview). Improvement results are not listed in the heading.

Nutrition/Meals

- Research in which AI determines taste and nutrition from food photos (Bioengineer.org). Accuracy, data scale, and evidence level are unknown. - Video of J&J CEO Duato talking about obesity, cancer, and AI (Bloomberg). See “12. Remarks from dignitaries.”

Prevention/Medical checkup

- Breast cancer risk prediction AI enters direct-to-consumer sales (DTC) (STAT). Utah's sandbox has raised regulatory concerns. Target population and accuracy unknown. - YD Bio launches AI cancer risk assessment tool for $10 (Investing.com). Target population and verification unknown.

Self-management of chronic diseases

- Research report (Bioengineer.org, American Heart Association): Leading AI tools were able to correctly identify only about two-thirds of validated home blood pressure monitors. The content is that there is an issue with the reliability of device selection by AI. The number of tools being evaluated and the level of evidence are unclear from the headline.

Elderly people/nursing care

- UK: £80 million public offering to test AI and digital tools for dementia (Digital Health). There are no results yet. - Research to detect swallowing disorders early using AI (Bioengineer.org). The scale and accuracy are unknown. - Small AI model challenges 'bigger is better' idea in longevity research (Arab News) - Economics Observatory: An article discussing whether unemployment caused by AI will lead to solving the shortage of care workers. - AI model for battery deterioration (Springwise) has been excluded as it has nothing to do with health.

Digital treatment/regulation

- US: Wellysis' AI electrocardiogram analysis software S-Patch CardioAI received FDA 510(k) approval. - US: State-by-state AI rules could delay patient access, says state (MobiHealthNews). - US: RadNet cites a study that estimated that the use of AI could reduce prostate biopsies by 18.9%. This is an estimate based on modeling (simulation) and is not confirmed in actual clinical practice. - South Korea: The Ministry of Health and Welfare has issued guidelines due to concerns about the expansion of use and dependence on AI mental health counseling (Chosunbiz). - Utah, USA: Regulatory Concerns in AI Regulatory Sandbox (STAT).

Workplace health

- IBM Incident Response Manager: Based on 26 years of experience, says he is more concerned about burnout than AI (Fortune). - HR Executive: A discussion on how to stop treating resistance to AI as a change management problem. - BW People: Articles about the human aspects of AI implementation. - All of them are just headlines, and the specific measures and measurement results of the system/operation are unknown.

Japanese movements

- Government guidelines: It is said that 70% of people seek solace from generated AI, and the government has provided guidelines (headline of Chosun Ilbo), but it is not possible to tell from the headline whether it is the Japanese government or the South Korean government, so it is necessary to check the text. This may be the same topic as the South Korean Ministry of Health and Welfare's guideline report on the same day. - Kyoshin: Filed a patent for interpersonal service support technology using AI in the education and nursing care fields. - Now accepting consultations for a physical burden visualization program for corporations that combines AI posture analysis and industrial accident risk analysis (PR TIMES). - eatas: Started providing "AI dietary diagnosis" in collaboration with AI Impulse (online nutritional guidance service). - New movements by ministries, local governments, and insurers cannot be confirmed from headlines.

Remarks from VIPs

- Joaquin Duato (CEO of Johnson & Johnson): Talked about obesity, cancer, and AI on The David Rubenstein Show. The main point is unclear from the headline. - IBM's head of cyber response (name not listed in headline): Said he was more concerned about burnout than AI. - The list of important people being tracked was blank.

AI video/commentary

- J&J CEO's appearance on Bloomberg's The David Rubenstein Show is the only video. Contents not confirmed.